The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its price objective lowered by Lake Street Capital from $22.00 to $19.00 in a research note issued to investors on Wednesday morning, The Fly reports. Other equities research analysts also recently issued research reports about the stock. Maxim Group increased their target price on shares of Achieve […]
Achieve Life Sciences (ACHV) Prices 3M Share Offering at $5 50/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Achieve Life Sciences (NASDAQ:ACHV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends. Valuation and Earnings This table compares Virax […]